Core Viewpoint - 3D Systems will announce its financial results for Q1 2025 on May 12, 2025, with a conference call scheduled for May 13, 2025, at 8:30 a.m. Eastern Time [1][2]. Company Overview - 3D Systems was founded over 35 years ago by Chuck Hull, who aimed to enhance product design and manufacturing through 3D printing, leading to the establishment of the additive manufacturing industry [3]. - The company provides comprehensive 3D printing solutions, including technologies, materials, and software, targeting high-value markets such as medical, aerospace, transportation, AI infrastructure, and durable goods [3]. - 3D Systems is committed to transforming manufacturing for a better future, driven by the expertise and passion of its employees [3].

Financial Data and Key Metrics Changes - Total revenue increased year-over-year by more than 4% to €66.4 million, while EBIT for Q1 2025 amounted to €0.6 million [24] - The net result for the quarter was a loss of €0.5 million or €0.01 per share, impacted by unfavorable exchange rate fluctuations [24][37] - Free cash flow was positive, reinforcing the net cash position to €67.7 million, an increase of almost €7 million compared to the beginning of the quarter [24][40] Business Line Data and Key Metrics Changes - Materialise Medical revenue grew almost 19%, driven by both Medical Software and Medical Devices sales, which increased by 14% and 21% respectively [26][29] - Software segment revenue decreased by 6% to €9.8 million due to revenue deferral, although more than 80% of Software revenue was recurring [31][56] - Manufacturing segment revenues decreased by 5.5% compared to Q1 2024, but increased by 12% compared to Q4 2024 [33] Market Data and Key Metrics Changes - Aerospace segment sales grew by 23% year-over-year, while industrial and automotive segments faced challenges [21][33] - The total deferred income position increased to €61 million, with €49 million related to Software licenses and maintenance contracts [40] Company Strategy and Development Direction - The company aims to cut absolute emissions by 55% by 2029 compared to the 2019 baseline, having already reduced emissions by 32% in 2024 [9][10] - Materialise is focusing on scaling additive manufacturing and enhancing software solutions to facilitate broader adoption [11][16] - The company is reassessing its involvement in the defense sector to strengthen its aerospace segment and create new opportunities [22] Management Comments on Operating Environment and Future Outlook - Management expects Q2 to be more challenging but anticipates stabilization in the second half of 2025, maintaining revenue guidance of €270 million to €285 million for the full year [43] - The current geopolitical landscape and macroeconomic conditions are expected to weigh on results, particularly in Q2 [43] Other Important Information - The company launched a clinical trial for a 3D-printed tracheal splint for infants, which could open new market opportunities [15] - Significant R&D investments continued, with over €11 million spent in Q1, primarily in the Medical segments [35] Q&A Session Summary Question: Impact of tariffs on Materialise - Management indicated that the U.S. manufacturing plant mitigates tariff impacts, while raw materials may be affected [48][50] Question: Q2 outlook - Management expects Q2 to be flat on the topline with uncertainty in the market, predicting pressure on the bottom line [52][54] Question: Software revenue performance - Software revenue was below €10 million for the first time since COVID, but over 80% of Software revenue is now recurring, indicating a positive trend [55][56]

Financial Data and Key Metrics Changes - Total revenue increased by more than 4% year-over-year to €66.4 million in Q1 2025, while EBIT amounted to €600,000, and the net result was a loss of €500,000 or €0.01 per share [17][18][25] - The net cash position at the end of Q1 was €67.7 million, an increase of almost €7 million compared to the beginning of the quarter [17][27] Business Line Data and Key Metrics Changes - Materialise Medical revenue grew by almost 19%, while Software and Manufacturing segments saw revenue decreases of around 6% each [18][20] - Adjusted EBITDA for Materialise Medical increased to over €9 million with a stable margin of 29%, while Software segment adjusted EBITDA decreased to €600,000 with a margin of 6.1% [21][22] Market Data and Key Metrics Changes - The aerospace segment in Manufacturing saw a sales growth of 23% compared to Q1 2024, while overall Manufacturing revenues decreased by 5.5% year-over-year [16][24] - The total deferred revenue related to software maintenance and license fees increased by €1.9 million, totaling almost €49 million [19] Company Strategy and Development Direction - The company aims to scale additive manufacturing and improve efficiency through advanced software solutions, with a focus on overcoming barriers to adoption [9][13] - Materialise is reassessing its involvement in the defense sector to strengthen its position in aerospace and create new opportunities [16] Management Comments on Operating Environment and Future Outlook - Management expects Q2 2025 to be challenging but anticipates stabilization in the second half of the year, maintaining guidance for consolidated revenue between €270 million and €285 million for the full year [29][30] - The transition to a recurring revenue model in the Software segment is progressing, with over 80% of software revenue now recurring [40][42] Other Important Information - The company published its 2024 sustainability report, aiming to cut absolute emissions by 55% by 2029 compared to the 2019 baseline [7][8] Q&A Session Summary Question: Impact of tariffs on Materialise - Management indicated that the US manufacturing plant mitigates tariff impacts, but raw materials may be affected, and the biggest concern is the potential impact on customers [35][36] Question: Outlook for Q2 - Management expects Q2 to be a difficult quarter, with a flattish top line anticipated, but uncertainty remains high [37][38] Question: Software revenue performance - Software revenue was below €10 million for the first time since the beginning of COVID, but deferred revenue is growing, and over 80% of software revenue is now recurring [39][40][41]

Core Insights - Velo3D has entered a five-year, $15 million master services agreement with Momentus to enhance operational efficiency and drive future success through its new Rapid Production Solutions offering [1][2] - The partnership aims to support mission-critical projects and aligns with Velo3D's long-term growth strategy, providing exceptional value over the next five years [2] - Velo3D's Rapid Production Solutions address the need for innovation and flexibility in manufacturing, enabling customers to accelerate their production capabilities [3][6] Company Overview - Velo3D is a leading U.S. metal 3D printing technology company that has transformed aerospace and defense supply chains through advanced additive manufacturing [1][4] - The company has developed a fully integrated solution that includes Flow print preparation software, Sapphire printers, and Assure quality control systems, powered by its Intelligent Fusion manufacturing process [4] - Velo3D has established partnerships with notable companies such as SpaceX, Lockheed Martin, and General Motors, and was recognized as one of Fast Company's Most Innovative Companies for 2023 [4] Industry Context - The additive manufacturing industry has faced limitations for nearly 30 years, but Velo3D has overcome these challenges, allowing for the production of high-value metal parts previously deemed impossible [3][4] - Velo3D's solutions enable rapid innovation in production-ready manufacturing, particularly in aerospace, defense, and energy sectors, allowing companies to shorten design cycles and achieve production qualification faster [6] - The Rapid Production Solutions offering provides flexible production pathways, including vertical integration within customer operations and partnerships with contract manufacturers, facilitating scalable production without significant capital investment [6]

Industry Overview - 3D Printing, also known as additive manufacturing, has evolved since the 1980s, revolutionizing manufacturing processes by allowing the creation of three-dimensional objects layer by layer from digital designs [2] - The technology offers advantages over traditional manufacturing, including cost-effectiveness, customization, precision, and sustainability [2] - The global 3D Printing market is projected to grow at a compound annual growth rate (CAGR) of 23.4%, reaching $19.33 billion by 2024 [7] Market Segmentation - The healthcare sector is expected to see a CAGR of 17.5% from 2024 to 2029, with the market estimated at $1.17 billion in 2024 [6] - North America holds the largest share of the 3D Printing market at 41.4% in 2024, while Asia-Pacific is leading in healthcare 3D Printing growth [6][7] Key Players - Xometry, Proto Labs Inc., and Stratasys, Ltd. are identified as top players in the 3D Printing space [3] - NVIDIA has significantly influenced the industry through advanced AI and GPU technologies, enhancing various facets of additive manufacturing [10] - GE Aerospace has been a pioneer in additive manufacturing since the 1980s, producing complex components for jet engines and increasing fuel efficiency [16][17] Technological Advancements - NVIDIA's partnership with HP's 3D Printing division has led to improved efficiency and accuracy in manufacturing processes [11] - GE Aerospace's use of 3D Printing has resulted in a 10% increase in fuel efficiency for the GE9X engine compared to its predecessor [17] - Proto Labs has expanded its capabilities with advanced photopolymers technology, generating around $84 million in revenues from its 3D Printing service in 2024 [26] Investment Opportunities - Companies like NVIDIA, GE Aerospace, Carpenter Technology, and Proto Labs are highlighted as lucrative investment opportunities due to their strong growth prospects in the 3D Printing sector [8][19][22][26]

Financial Data and Key Metrics Changes - In Q4 2024, consolidated revenue was $150.4 million, down 3.8% year-over-year. For the full year, consolidated revenue declined 8.8% to $572.5 million compared to $627.6 million in 2023 [31][33]. - Adjusted gross margin for Q4 was 49.6%, up from 48.8% in the same period last year. For the full year, non-GAAP gross margin improved by 100 basis points to 49.2% [35][36]. - GAAP net loss for Q4 was $41.9 million, or $0.59 per diluted share, compared to a net loss of $15 million, or $0.22 per diluted share, in the same period last year [39]. Business Line Data and Key Metrics Changes - Product revenue in Q4 fell by 4.8% to $105.1 million, with systems revenue down 1.5% to $46.7 million. Consumable revenue decreased by 7.3% to $58.4 million [31][32]. - For the full year, product revenue was $392 million, down from $433.7 million in 2023. Consumables revenue increased by 2.3% to $251.7 million [33][34]. Market Data and Key Metrics Changes - The company generated 36% of its revenues from manufacturing in 2024, up from 34% in 2023, indicating a shift towards end-part manufacturing [10]. - The dental market opportunity is projected to reach nearly $2.5 billion by 2028, with significant interest in the TrueDent resin [23][79]. Company Strategy and Development Direction - The company is focused on enhancing its leadership in additive manufacturing and is committed to right-sizing the business while maintaining R&D resources [9][51]. - The strategy includes a focus on high-value applications, particularly in manufacturing and the dental sector, with plans to expand its product offerings and customer base [10][80]. Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future growth despite current macroeconomic challenges, emphasizing the long-term value proposition of additive manufacturing [56][108]. - The outlook for 2025 anticipates revenue in the range of $570 million to $585 million, with expectations for sequential growth throughout the year [45]. Other Important Information - The company ended Q4 with $150.7 million in cash and equivalents, with no debt, providing a stable financial position to support growth initiatives [12][44]. - A $120 million investment from Fortissimo Capital is expected to close in Q2 2025, which will further strengthen the company's financial position [13][44]. Q&A Session Summary Question: Market conditions and revenue cadence for 2025 - Management acknowledged current downturns but highlighted strong customer engagement and a focus on reliability and effectiveness of equipment as key areas of customer interest [56][58]. Question: Gross margin guidance for 2025 - Management indicated that gross margins are expected to remain stable, with improvements anticipated as cost-saving measures take effect [62][64]. Question: Organic revenue growth and FX impacts - Management noted minimal impact from divestitures and hedging strategies in place to mitigate FX risks [75][76]. Question: Consumables revenue decline - Management described Q4 as an outlier and expressed confidence in a rebound in consumables revenue for 2025 [88]. Question: Acquisition targets and strategy - Management emphasized a clear strategy focused on shareholder value and indicated interest in opportunities that align with their long-term goals [97][102]. Question: Market verticals with confidence - Management identified dental, aerospace, and tooling as key verticals with growth potential, while remaining cautious about overall market conditions [112][113].

Stratasys Ltd. (NASDAQ:SSYS) Q4 2024 Earnings Conference Call March 5, 2025 8:30 AM ET Company Participants Yonah Lloyd - Chief Communications Officer and Vice President, Investor Relations Yoav Zeif - Chief Executive Officer Eitan Zamir - Chief Financial Officer Conference Call Participants Greg Palm - Craig-Hallum Troy Jensen - Cantor Fitzgerald Jim Ricchiuti - Needham & Company Ananda Baruah - Loop Capital Markets Operator Greetings, and welcome to the Stratasys Q4 2024 Earnings Conference Call and Webca ...